{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:30:23Z","timestamp":1792193423322,"version":"4.4.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,8,26]],"date-time":"2011-08-26T00:00:00Z","timestamp":1314316800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s11926-011-0207-5","type":"journal-article","created":{"date-parts":[[2011,8,25]],"date-time":"2011-08-25T06:58:20Z","timestamp":1314255500000},"page":"482-488","source":"Crossref","is-referenced-by-count":53,"title":["Vasculitis in Sj\u00f6gren\u2019s Syndrome"],"prefix":"10.1007","volume":"13","author":[{"given":"R. Hal","family":"Scofield","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,8,26]]},"reference":[{"key":"207_CR1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0140-6736(05)66990-5","volume":"366","author":"RI Fox","year":"2005","unstructured":"Fox RI. Sj\u00f6gren\u2019s syndrome. Lancet. 2005;366:321\u201331.","journal-title":"Lancet"},{"key":"207_CR2","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sj\u00f6gren\u2019s syndrome: a revisal of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61:554\u20138.","journal-title":"Ann Rheum Dis"},{"key":"207_CR3","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/art.1780270205","volume":"27","author":"TE Daniels","year":"1984","unstructured":"Daniels TE. Labial salivary gland biopsy in Sj\u00f6gren\u2019s syndrome. Assessment as a diagnostic criterion in 362 suspected cases. Arthritis Rheum. 1984;27:147\u201356.","journal-title":"Arthritis Rheum"},{"key":"207_CR4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/art.23177","volume":"58","author":"CG Helmick","year":"2008","unstructured":"Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, et al. National Arthritis Data Workgroup. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum. 2008;58:15\u201325.","journal-title":"Arthritis Rheum"},{"key":"207_CR5","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s12016-007-8003-8","volume":"32","author":"JG Routsias","year":"2007","unstructured":"Routsias JG, Tzioufas AG. Sj\u00f6gren\u2019s syndrome\u2014study of autoantigens and autoantibodies. Clin Rev All Immunol. 2007;32:238\u201351.","journal-title":"Clin Rev All Immunol"},{"key":"207_CR6","doi-asserted-by":"crossref","first-page":"R47","DOI":"10.1186\/ar2958","volume":"12","author":"VK Bournia","year":"2007","unstructured":"Bournia VK, Diamanti KD, Vlachoyiannopoulos PG, Moutsopoulos HM. Anticentromere antibody positive Sjogren\u2019s syndrome: a retrospective descriptive analysis. Arthritis Res Ther. 2007;12:R47.","journal-title":"Arthritis Res Ther"},{"key":"207_CR7","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.0300-9475.2004.01395.x","volume":"59","author":"D Cavill","year":"2004","unstructured":"Cavill D, Waterman SA, Gordon TP. Antibodies raised against the second extracellular loop of the human muscarinic M3 receptor mimic functional autoantibodies in Sjogren\u2019s syndrome. Scand J Immunol. 2004;59:261\u20136.","journal-title":"Scand J Immunol"},{"key":"207_CR8","doi-asserted-by":"crossref","unstructured":"\u2022 Wandinger K-P, Stangel M, Witte T, Venables P, Charles P, Jarius S, Wildemann B, Probst C, Iking-Konert C. Autoantibodies against aquaporin-4 in patients with neuropsychiatric systemic lupus erythematosus and primary Sj\u00f6gren\u2019s syndrome. Arthritis Rheum 2010; 62:1198\u20131200. This paper demonstrates that Sj\u00f6gren\u2019s syndrome patients with Devic disease transverse myelitis have antibodies to aquaporin-4. These antibodies are also found in the serum of patients with Devic disease (neuromyelitis optica).","DOI":"10.1002\/art.27337"},{"key":"207_CR9","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s11926-003-0010-z","volume":"5","author":"R Jonsson","year":"2003","unstructured":"Jonsson R, Gordon TP, Konttinen YT. Recent advances in understanding molecular mechanisms in the pathogenesis and antibody profile of Sjogren\u2019s syndrome. Curr Rheumatol Rep. 2003;5:311\u20136.","journal-title":"Curr Rheumatol Rep"},{"key":"207_CR10","doi-asserted-by":"crossref","unstructured":"\u2022 Birnbaum J. Peripheral nervous system manifestations of Sjogren syndrome: clinical patterns, diagnostic paradigms, etiopathogenesis, and therapeutic strategies. Neurologist 2010; 16:287\u2013297. This is a comprehensive review of neurological disease among Sj\u00f6gren\u2019s syndrome patients.","DOI":"10.1097\/NRL.0b013e3181ebe59f"},{"key":"207_CR11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00000441-189801000-00002","volume":"115","author":"W Osler","year":"1898","unstructured":"Osler W. On chronic symmetrical enlargement of the salivary and lacrimal glands. Am J Med Sci. 1898;115:27\u201330.","journal-title":"Am J Med Sci"},{"key":"207_CR12","volume-title":"A new conception of Keratoconjunctivitis Sicca","author":"JB Hamilton","year":"1943","unstructured":"Hamilton JB. A new conception of Keratoconjunctivitis Sicca. Sydney: Australian Medical Publishing Co; 1943."},{"key":"207_CR13","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/1523-1747.ep12552002","volume":"80","author":"EL Alexander","year":"1983","unstructured":"Alexander EL, Provost TT. Cutaneous manifestations of primary Sjogren\u2019s syndrome: a reflection of vasculitis and association with anti-Ro(SSA) antibodies. J Invest Dermatol. 1983;80:386\u201391.","journal-title":"J Invest Dermatol"},{"key":"207_CR14","doi-asserted-by":"crossref","first-page":"155","DOI":"10.7326\/0003-4819-98-2-155","volume":"98","author":"EL Alexander","year":"1983","unstructured":"Alexander EL, Arnett FC, Provost TT, Stevens MB. Sjogren\u2019s syndrome: association of anti-Ro(SS-A) antibodies with vasculitis, hematologic abnormalities, and serologic hyperreactivity. Ann Intern Med. 1983;98:155\u20139.","journal-title":"Ann Intern Med"},{"key":"207_CR15","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/art.1780281109","volume":"28","author":"R Molina","year":"1985","unstructured":"Molina R, Provost TT, Alexander EL. Two types of inflammatory vascular disease in Sjogren\u2019s syndrome. Differential association with seroreactivity to rheumatoid factor and antibodies to Ro (SS-A) and with hypocomplementemia. Arthritis Rheum. 1985;28:1251\u20138.","journal-title":"Arthritis Rheum"},{"key":"207_CR16","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/01.md.0000119465.24818.98","volume":"83","author":"M Ramos-Casals","year":"2004","unstructured":"Ramos-Casals M, Anaya JM, Garcia-Carrasco M, Rosas J, Bove A, Claver G, et al. Cutaneous vasculitis in primary Sjogren syndrome: classification and clinical significance of 52 patients. Medicine. 2004;83:96\u2013106.","journal-title":"Medicine"},{"key":"207_CR17","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/MD.0b013e318181e6af","volume":"87","author":"M Ramos-Casals","year":"2008","unstructured":"Ramos-Casals M, Solans R, Rosas J, Camps MT, Gil A, Del Pino-Montes J, et al. GEMESS Study Group: primary Sjogren syndrome in Spain: clinical and immunologic expression in 1010 patients. Medicine. 2008;87:210\u20139.","journal-title":"Medicine."},{"key":"207_CR18","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s10067-009-1359-9","volume":"29","author":"D Gulati","year":"2010","unstructured":"Gulati D, Kushner I, Elizabeth File E, Magrey M. Primary Sjogren\u2019s syndrome with anticentromere antibodies\u2014a clinically distinct subset. Clin Rheumatol. 2010;29:789\u201391.","journal-title":"Clin Rheumatol"},{"key":"207_CR19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1365-2133.2000.03597.x","volume":"143","author":"P Rovel-Guitera","year":"2000","unstructured":"Rovel-Guitera P, Diemert MC, Charuel JL, Laporte JL, Musset L, Chosidow O, et al. IgA antineutrophil cytoplasmic antibodies in cutaneous vasculitis. Br J Dermatol. 2000;143:99\u2013103.","journal-title":"Br J Dermatol"},{"key":"207_CR20","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/BF02249025","volume":"13","author":"HM Markusse","year":"1994","unstructured":"Markusse HM, Schoonbrood M, Oudkerk M, Henzen-Logmans SC. Leucocytoclastic vasculitis as presenting feature of primary Sjogren\u2019s syndrome. Clin Rheumatol. 1994;13:269\u201372.","journal-title":"Clin Rheumatol"},{"key":"207_CR21","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1365-4632.2007.03229.x","volume":"46","author":"R Cardoso","year":"2007","unstructured":"Cardoso R, Goncalo M, Tellechea O, Maia R, Borges C, Silva JA, et al. Livedoid vasculopathy and hypercoagulability in a patient with primary Sjogren\u2019s syndrome. Internat J Dermatol. 2007;46:431\u20134.","journal-title":"Internat J Dermatol"},{"key":"207_CR22","first-page":"789","volume":"23","author":"KG Capobianco","year":"2005","unstructured":"Capobianco KG, Xavier RM, Bredemeier M, Restelli VG, Brenol JC. Nailfold capillaroscopic findings in primary Sjogren\u2019s syndrome: clinical and serological correlations. Clin Exp Rheumatol. 2005;23:789\u201394.","journal-title":"Clin Exp Rheumatol"},{"key":"207_CR23","first-page":"S102","volume":"24","author":"M Ballard","year":"2006","unstructured":"Ballard M, Meyer O, Adle-Biassette H, Grossin M. Jaccoud\u2019s arthropathy with vasculitis and primary Sjogren\u2019s syndrome. A new entity. Clin Exp Rheumatol. 2006;24:S102\u2013103.","journal-title":"Clin Exp Rheumatol"},{"key":"207_CR24","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/ana.410110614","volume":"11","author":"EL Alexander","year":"1982","unstructured":"Alexander EL, Craft C, Dorsch C, Moser RL, Provost TT, Alexander GE. Necrotizing arteritis and spinal subarachnoid hemorrhage in Sjogren syndrome. Ann Neurol. 1982;11:632\u20135.","journal-title":"Ann Neurol"},{"key":"207_CR25","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/ajcp\/88.1.26","volume":"88","author":"M Tsokos","year":"1987","unstructured":"Tsokos M, Lazarou SA, Moutsopoulos HM. Vasculitis in primary Sjogren\u2019s syndrome. Histologic classification and clinical presentation. Am J Clin Pathol. 1987;88:26\u201331.","journal-title":"Am J Clin Pathol"},{"key":"207_CR26","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00005792-200207000-00003","volume":"81","author":"M Garcia-Carrasco","year":"2002","unstructured":"Garcia-Carrasco M, Ramos-Casals M, Rosas J, Pallares L, Calvo-Alen J, Cervera R, et al. Primary Sjogren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients. Medicine. 2002;81:270\u201380.","journal-title":"Medicine"},{"key":"207_CR27","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s10165-008-0072-x","volume":"18","author":"S Yukawa","year":"2008","unstructured":"Yukawa S, Tahara K, Yukawa N, Shoji A, Tsuji S, Hayashi H, et al. Dramatic regression of mesenteric abnormalities demonstrated on angiography following prednisolone and cyclophosphamide combination therapy in a patient with polyarteritis nodosa associated with Sjogren\u2019s syndrome. Mod Rheumatol. 2008;18:416\u201321.","journal-title":"Mod Rheumatol"},{"key":"207_CR28","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s00296-009-1045-x","volume":"30","author":"V Yazisiz","year":"2010","unstructured":"Yazisiz V, Ozbudak IH, Nizam I, Erbasan F, Avci AB, Ozbudak O, et al. A case of primary Sjogren\u2019s syndrome with pulmonary-limited Wegener\u2019s granulomatosis. Rheumatol Internat. 2010;30:1235\u20138.","journal-title":"Rheumatol Internat"},{"key":"207_CR29","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/rheumatology\/39.7.805","volume":"39","author":"G Karargyris","year":"2000","unstructured":"Karargyris G, Stamatopoulos K, Kittas C, et al. Sj\u00f6gren\u2019s syndrome co-existing with limited Wegener\u2019s granulomatosis. Rheumatol (Oxford). 2000;39:805\u20136.","journal-title":"Rheumatol (Oxford)"},{"key":"207_CR30","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/art.1780351120","volume":"35","author":"EP B\u00f6ttinger","year":"1992","unstructured":"B\u00f6ttinger EP, Niles JL, Collins AB, et al. Antineutrophil cytoplasmic autoantibody-associated vasculitis presenting as Sj\u00f6gren\u2019s syndrome. Arthritis Rheum. 1992;35:1373\u20136.","journal-title":"Arthritis Rheum"},{"key":"207_CR31","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10165-009-0180-2","volume":"19","author":"D Wakasugi","year":"2009","unstructured":"Wakasugi D, Kato T, Gono T, Ito E, Nodera H, Kawaguchi Y, et al. Extreme efficacy of intravenous immunoglobulin therapy for severe burning pain in a patient with small fiber neuropathy associated with primary Sjogren\u2019s syndrome. Mod Rheumatol. 2009;19:437\u201340.","journal-title":"Mod Rheumatol"},{"key":"207_CR32","doi-asserted-by":"crossref","unstructured":"\u2022 Morozumi S, Kawagashira Y, Iijima M, Koike H, Hattori N, Katsuno M, Tanaka F, Sobue G. Intravenous immunoglobulin treatment for painful sensory neuropathy associated with Sjogren\u2019s syndrome. J Neurol Sci 2009; 279:57\u201361. This is a report on a series of five patients treated with IV IgG. There is not a randomized, blinded trial of such therapy in Sj\u00f6gren\u2019s syndrome, and none is likely forthcoming. Small case series are the best evidence available for treatment of neuropathy.","DOI":"10.1016\/j.jns.2008.12.018"},{"key":"207_CR33","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1136\/jnnp.2005.084533","volume":"77","author":"M Kizawa","year":"2006","unstructured":"Kizawa M, Mori K, Iijima M, Koike H, Hattori N, Sobue G. Intravenous immunoglobulin treatment in painful sensory neuropathy without sensory ataxia associated with Sjogren\u2019s syndrome. J Neurol Neurosurg Psych. 2006;77:967\u20139.","journal-title":"J Neurol Neurosurg Psych"},{"key":"207_CR34","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1212\/WNL.61.6.873","volume":"61","author":"GI Wolfe","year":"2003","unstructured":"Wolfe GI, Nations SP, Burns DK, Herbelin LL, Barohn RJ. Benefit of IVIg for long-standing ataxic sensory neuronopathy with Sjogren\u2019s syndrome. Neurol. 2003;61:873.","journal-title":"Neurol"},{"key":"207_CR35","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1136\/ard.2002.003996","volume":"62","author":"Y Levy","year":"2003","unstructured":"Levy Y, Uziel Y, Zandman GG, Amital H, Sherer Y, Langevitz P, et al. Intravenous immunoglobulins in peripheral neuropathy associated with vasculitis. Ann Rheum Dis. 2003;62:1221\u20133.","journal-title":"Ann Rheum Dis"},{"key":"207_CR36","first-page":"503","volume":"60","author":"Y Takahashi","year":"2003","unstructured":"Takahashi Y, Takata T, Hoshino M, Sakurai M, Kanazawa I. Benefit of IVIG for long-standing ataxic sensory neuronopathy with Sjogren\u2019s syndrome. IV immunoglobulin. eurol. 2003;60:503\u20135.","journal-title":"eurol"},{"key":"207_CR37","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1177\/096120339700600605","volume":"6","author":"TD Golan","year":"1997","unstructured":"Golan TD, Keren D, Elias N, Naschitz JE, Toubi E, Misselevich I, et al. Severe reversible cardiomyopathy associated with systemic vasculitis in primary Sjogren\u2019s syndrome. Lupus. 1997;6:505\u20138.","journal-title":"Lupus."},{"key":"207_CR38","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1136\/ard.2006.060905","volume":"66","author":"JM Woerkom van","year":"2007","unstructured":"van Woerkom JM, Kruize AA, Geenen R, van Roon EN, Goldschmeding R, Verstappen SM, et al. Safety and efficacy of leflunomide in primary Sjogren\u2019s syndrome: a phase II pilot study. Ann Rheum Dis. 2007;66:1026\u201332.","journal-title":"Ann Rheum Dis"},{"key":"207_CR39","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1007\/s10067-008-0944-7","volume":"27","author":"IF Horvath","year":"2008","unstructured":"Horvath IF, Szodoray P, Zeher M. Primary Sjogren\u2019s syndrome in men: clinical and immunological characteristic based on a large cohort of Hungarian patients. Clin Rheumatol. 2008;27:1479\u201383.","journal-title":"Clin Rheumatol"},{"key":"207_CR40","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/rheumatology\/kem079","volume":"46","author":"P Brito-Zeron","year":"2007","unstructured":"Brito-Zeron P, Ramos-Casals M, Bove A, Sentis J, Font J. Predicting adverse outcomes in primary Sjogren\u2019s syndrome: identification of prognostic factors. Rheumatol. 2007;46:1359\u201362.","journal-title":"Rheumatol"},{"key":"207_CR41","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","volume":"53","author":"DM Wingerchuk","year":"1999","unstructured":"Wingerchuk DM, Hogancamp WF, O\u2019Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic\u2019s syndrome). Neurology. 1999;53:1107\u201314.","journal-title":"Neurology"},{"key":"207_CR42","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","volume":"364","author":"VA Lennon","year":"2004","unstructured":"Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004;364:2106\u201312.","journal-title":"Lancet"},{"key":"207_CR43","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","volume":"202","author":"VA Lennon","year":"2005","unstructured":"Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med. 2005;202:473\u20137.","journal-title":"J Exp Med"},{"key":"207_CR44","doi-asserted-by":"crossref","first-page":"G247","DOI":"10.1152\/ajpgi.2001.281.1.G247","volume":"281","author":"V Gresz","year":"2001","unstructured":"Gresz V, Kwon TH, Hurley PT, Varga G, Zelles T, Nielsen S, et al. Identification and localization of aquaporin water channels in human salivary glands. Am J Physiol Gastrointest Liver Physiol. 2001;281:G247\u201354.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"207_CR45","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","volume":"66","author":"DM Wingerchuk","year":"2006","unstructured":"Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006;66:1485\u20139.","journal-title":"Neurology"},{"key":"207_CR46","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/BF01784137","volume":"64","author":"T Poralla","year":"1986","unstructured":"Poralla T, Trautmann F, Rumpelt HJ, Fries J, Eckhardt R, Hutteroth TH, et al. A case of Sjogren\u2019s syndrome with severe anemia due to myelitis. Klinische Wochenschrift. 1986;64:92\u20135.","journal-title":"Klinische Wochenschrift"},{"key":"207_CR47","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/archneurol.2007.17","volume":"65","author":"SJ Pittock","year":"2008","unstructured":"Pittock SJ, Lennon VA, de Seze J, Vermersch P, Homburger HA, Wingerchuk DM, et al. Neuromyelitis optica and non organ-specific autoimmunity. Arch Neurol. 2008;65:78\u201383.","journal-title":"Arch Neurol"},{"key":"207_CR48","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Wandinger KP, Stangel M, Witte T, Venables P, Charles P, Jarius S, Wildemann B, Probst C, Iking-Konert C, Schneider M. Autoantibodies against aquaporin-4 in patients with neuropsychiatric systemic lupus erythematosus and primary Sjogren\u2019s syndrome. Arthritis Rheum 2010; 62:1198\u20131200. NMO-IgG and anti-aquaporin were only found in Sj\u00f6gren\u2019s syndrome patients who had manifestations of Devic disease\u2014namely, recurrent optic neuritis or longitudinally extensive transverse myelitis.","DOI":"10.1002\/art.27337"},{"key":"207_CR49","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Kahlenberg JM. Neuromyelitis optica spectrum disorder as an initial presentation of primary Sj\u00f6gren\u2019s syndrome. Semin Arthritis Rheum 2011; 40:343\u2013348. This is a complete review of the literature concerning the association of Sj\u00f6gren\u2019s syndrome and Devic disease.","DOI":"10.1016\/j.semarthrit.2010.05.005"},{"key":"207_CR50","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1177\/1352458508088941","volume":"14","author":"A Javed","year":"2008","unstructured":"Javed A, Balabanov R, Arnason BG, Kelly TJ, Sweiss NJ, Pytel P, et al. Minor salivary gland inflammation in Devic\u2019s disease and longitudinally extensive myelitis. Mult Scler. 2008;14:809\u201314.","journal-title":"Mult Scler"},{"key":"207_CR51","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/jnnp.2005.075861","volume":"84","author":"A Theodoridou","year":"2008","unstructured":"Theodoridou A, Settas L. Demyelination in rheumatic diseases. Postgrad Med J. 2008;84:127\u201332.","journal-title":"Postgrad Med J"},{"key":"207_CR52","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nri2529","volume":"9","author":"B Diamond","year":"2009","unstructured":"Diamond B, Huerta PT, Mina-Osorio P, Kowal C, Volpe BT. Losing your nerves? Maybe it\u2019s the antibodies. Nat Rev Immunol. 2009;9:449\u201356.","journal-title":"Nat Rev Immunol"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-011-0207-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-011-0207-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-011-0207-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T00:10:13Z","timestamp":1686269413000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-011-0207-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,26]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["207"],"URL":"https:\/\/doi.org\/10.1007\/s11926-011-0207-5","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,26]]}}}